Massachusetts regulators are rewriting how cannabis gets lab-tested, The Marijuana Herald reports. After a Nov. 12 meeting, the Cannabis Control Commission advanced several key decisions for both adult-use and medical products.
The big ones:
- Automatic retests. Labs would retest any sample that fails before issuing results, to separate real contamination from lab error.
- Test before every sale. Products would need compliance testing before being sold to another business or to customers.
- Remediation labels. Labels would have to say whether the cannabis was sanitized or remediated to cut contaminants.
- Targeted microbe testing for specific organisms that pose health concerns, instead of only broad microbial counts.
Quick explainer: "remediation" means treating a batch that failed a contaminant test so it can pass. The October draft would allow only two remediation attempts, and none for products that test positive for banned pesticides or plant growth regulators.
This is not final yet. Commissioners are expected to approve draft rules in December, with public comment starting in January and final rules tentatively in April 2027. The changes would kick in six months after that, with implementation anticipated in October 2027.
What it means for travelers: Nothing changes on shelves today. Eventually, Massachusetts labels should tell you more about how your flower was treated.






